COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 494

Article download: 146

Indian Journal of Obstetrics and Gynecology Research


Full Text PDF Share on Facebook Share on Twitter

Author Details : Khan Arshiya, Saxena Shivi

Volume : 2, Issue : 1, Year : 2015

Article Page : 11-15

Suggest article by email


Introduction: Gestational Diabetes Mellitus (GDM) has public health importance far beyond its immediate effect on the mother and child. Pregnancy is a diabetogenic state and GDM is a major driver of the Type 2 diabetes epidemic. About 1% - 3% of all pregnant women will show glucose intolerance. GDM is the most common metabolic complication that affects pregnant women. The frequency of GDM and its associated maternal, prenatal and long term morbidity emphasizes the importance of screening method.

Aim: To study the role of 50 gm glucose challenge test for screening of gestational diabetes
Method: Two hundred and fifty antenatal patients between 24-28 weeks of gestation were screened for gestational diabetes by 50 gm oral glucose challenge test. Those in whom plasma glucose was 130 gm /dl or higher were considered positive and then subjected to Glucose tolerance test (GTT 100 gm: 3 hour). Those with risk factors but negative GCT at 24-28 weeks were again screened at 32 –34 weeks. Comparison was made among normal patients and patients diagnosed with gestational diabetes regarding risk factors, clinical examination, routine and special investigations and pregnancy outcome
Results: Out of 250 patients 150 had no risk factors while 100 had one or more risk factors. 10 patients (4%) were diagnosed as having gestational diabetes. 8 patients were detected at 24-28 weeks and 2 were detected from the risk factor group at 32-34 weeks.
Conclusion: Universal screening of all pregnant patients during 24-28 weeks with glucose challenge test is simple, convenient, cheap and easy to organize instrument to identify women with GDM. In India we recommend universal screening of all pregnant women, as they have 11 fold increased risk of developing glucose intolerance during pregnancy compared to Caucasian women.

How to cite : Arshiya K, Shivi S, ROLE OF GLUCOSE CHALLENGE TEST FOR SCREENING OF GESTATIONAL DIABETES. Indian J Obstet Gynecol Res 2015;2(1):11-15

Copyright © 2015 by author(s) and Indian J Obstet Gynecol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (